Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors

Human Gene Therapy

Volumn 7, Issue 3, 1996, Pages 291-300

  Kramm, Christof M ^a,b,c   Rainov, Nikolai G ^a,b,d   Sena Esteves, Miguel ^a,b   Chase, Maureen ^a,b   Pechan, Peter A ^a,b   Chiocca, E Antonio ^a,b   Breakefield, Xandra O ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOTIDE REDUCTASE; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONTROLLED STUDY; FRONTAL LOBE; GENE REPLICATION; GENE TARGETING; GLIOSARCOMA; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; INTRATHECAL DRUG ADMINISTRATION; LEPTOMENINX; MALE; MARKER GENE; METASTASIS; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS; TOXICITY;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030065355     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.3-291     Document Type: Article

References (28)

1. ANDERSON, W.F., MILLER, A.D., and BORDIGNON, C. (eds.) (1995). ORDA reports. Recombinent DNA Advisory Committee (RAC). Data management report-December 1994. Hum. Gene Ther. 6, 535-548.
2. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G., and MASTRANGELI, A. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229-234.
3. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994a). Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5745-5751.
4. BOVIATSIS, E.J., CHASE, M., WEI, M., TAMIYA, T., HURFORD, R.K. JR., KOWALL, N.W., TEPPER, R.I., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994b). Gene transfer into experimental brain tumors mediated by adenovirus, herpes-simplex-virus (HSV), and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
5. BOVIATSIS, E.J., SCHARF, J.M., CHASE, M., HARRINGTON, K., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994c). Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther. 1, 323-331.
6. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
7. CLAY GOODMAN, J., TRASK, T.W., CHEN, S.-H., WOO, S.L.C., GROSSMAN, K.D., CAREY, G.B., HUBBARD, D.A., CARRIER, D.A., RAJAGOPAIAN, S., SHINE, H.D., and AGUILAR-CORDOVA, C.E. (1995). Toxicity of adenoviral mediated brain tumor gene therapy in primates. In Abstract Booklet for the International Conference on Gene Therapy for CNS Disorders, June 8-10, 1995, Philadelphia, Pennsylvania, Freese, A., Flamm, E.S., Cooperman, B.S., Wilson, J.M. (eds.), Abstract 2.10, p. 49.
8. COHEN, M.E., and DUFFNER, P.K. (eds.) (1994). Brain Tumors in Children. Principles of Diagnosis and Treatment, 2nd ed. (Raven Press, New York).
9. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-produced cells for treatment of experimental brain tumors. Science 256, 1550-1552.
10. EZZEDDINE, Z.C., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3, 608-614.
11. GOLDSTEIN, D.J., and WELLER, S.K. (1988). Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant. J. Virol. 62, 196-205.
12. KAPLITT, M.G., TJUVAJEV, J.G., LEIB, D.A., BERK, J., PETTIGREW, K.D., POSNER, J.B., PFAFF, D.W., RABKIN, S.D., and BLASBERG, R.G. (1994). Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. J. Neurooncol. 19, 137-147.
13. KORF, H.W., GOTZ, W., HERKEN, R., THEURING, F., GRUSS, P., and SCHACHENMAYR, W. (1990). S-antigen and rod-opsin immunoreactions in midline brain neoplasms of transgenic mice: similarities to pineal cell tumors and certain medulloblastomas in man. J. Neuropathol. Exp. Neurol. 49, 424-437.
14. MINETA, T., RABKIN, S.D., and MARTUZA, R.L. (1994). Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res. 54, 3963-3966.
15. OLDFIELD, E.H., RAM, Z., CULVER, K.W., BLAESE, R.M., DEVROOM, H.L., and ANDERSON, W.F. (1993). Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-69.
16. OLDFIELD, E.H., RAM, Z., CHIANG, Y., and BLAESE, R.M. (1995). Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI0108. A phase I/II study. Hum. Gene Ther. 6, 55-85.
17. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
18. RAFFEL, C., CULVER, K., KOHN, D., NELSON, M., SIEGEL, S., GILLIS, F., LINK, C.J., VILLABLANCA, J.G., and ANDERSON, W.F. (1994). Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum. Gene Ther. 5, 863-890.
19. RAM, Z., CULVER, K.W., WALLBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for treatment of brain tumors in rats. Cancer Res. 53, 83-88.
20. RAM, Z., WALLBRIDGE, S., OSHIRO, E.M., VIOLA, J.J., CHIANG, Y., MEULLER, S.N., BLAESE, R.M., and OLDFIELD, E.H. (1994). Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54, 2141-2145.
21. ROIZMAN, B., and SEARS, A.E. (1990). Herpes viruses and their replication. In Virology. B.N. Fields, and D.M. Knipe eds. (Raven Press, New York) vol. 2, pp. 1795-1841.
22. ROSS, B.D., BOKLYEK, and DAVIDSON, B.L. (1995). MRI and HMR5 assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral mediated transfer of the herpes simplex virus thymidine kinase gene. Clin. Cancer Res. (in press).
23. SCHARF, J.M., BOVIATSIS, E.J., FLEET, C., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994). Genetically modified rat 9L gliosarcoma cells facilitate detection of infiltrating tumor cells in a rat model of brain neoplasms. Transgenics 1, 219-224.
24. SWENBERG, J.A. (1977). Chemical- and virus-induced brain tumors. Natl. Cancer Inst. Monogr. 46, 3-10.
25. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1 thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
26. TURNER, D.L., SNYDER, E.Y., and CEPKO, C.L. (1990). Lineage-independent determination of cell type in the embryonic mouse retina. Neuron 4, 833-845.
27. VIOLA, J.J., RAM, Z., WALLBRIDGE, S., OSHIRO, E.M., TRAPNELL, B., TAO-CHENG, J.H., and OLDFIELD, E.H. (1995). Adenovirually mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J. Neurosurg. 82, 70-76.
28. WOOD, M.J.A., BYRNES, A.P., PFAFF, D.W., RABKIN, S.D., and CHARLTON, H.M. (1994). Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1, 283-291.